Spinal neurons exhibit a surprising capacity to learn and a hidden vulnerability when freed from the brain’s control James W. GrauMichelle A. Hook Invited Commentary Pages: 177 - 180
Unraveling molecular markers of biologic therapies in glioma Andrew B. LassmanLauren E. Abrey Clinical Trials Report Pages: 185 - 186
Medulloblastoma: Therapy and biologic considerations Timothy R. GershonOrren J. Becher OriginalPaper Pages: 200 - 206
Image-guided intensity-modulated radiation therapy of spine tumors Yoshiya YamadaMichael LovelockMark H. Bilsky OriginalPaper Pages: 207 - 211
Recent advances in the treatment of oligodendrogliomas Mark AgulnikWarren P. Mason OriginalPaper Pages: 212 - 217
Neurologic toxicities of cancer therapies Robert CavaliereDavid Schiff OriginalPaper Pages: 218 - 226
Remyelination strategies: New advancements toward a regenerative treatment in multiple sclerosis Martin StangelCorinna Trebst OriginalPaper Pages: 229 - 235
Demyelinating disorders: Update on transverse myelitis Chitra KrishnanAdam I. KaplinSanjay C. Keswani OriginalPaper Pages: 236 - 243
Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab Annette Langer-GouldLawrence Steinman OriginalPaper Pages: 253 - 258
Complementary and alternative medicine: Is there a role in multiple sclerosis? Vijayshree YadavDennis Bourdette OriginalPaper Pages: 259 - 267